SLC2A6 and neoplasm: In triple-negative breast cancer (TNBC), knockdown of YBX1 inhibited the expression of glycolytic genes (ENO1, SLC2A6, LDHA, PFKP, PGAM1, and GPI) and downregulated the expression of EMT-related genes and tumor migration and invasion [14].